Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers

Inclusion Criteria: * Subject is a healthy adult male or female volunteer aged 18 to 45 years, inclusive * Subject has a body mass index of 18 to 32 kg/m2, inclusive * Subject is able and willing to abstain from alcohol, grapefruit, caffeine * Subject has no clinically relevant abnormalities on the basis of medical history, physical examination, and vital signs Exclusion Criteria: * Subject has clinically relevant out-of-range prothrombin time (PT), activated partial thromboplastin time, fibrinogen, protein C, or protein S * Subject has abnormal prolongation of bleeding time at Screening * Subject has hematuria on urinalysis * Subject has personal or family history of coagulation or bleeding disorders